Legal aspects of zebrafish neuropharmacology and neurotoxicology research.
3Rs
Animal welfare regulations
Pharmacology
Toxicology
Journal
Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295
Titre abrégé: Regul Toxicol Pharmacol
Pays: Netherlands
ID NLM: 8214983
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
10
05
2018
revised:
13
11
2018
accepted:
15
11
2018
pubmed:
20
11
2018
medline:
25
1
2019
entrez:
20
11
2018
Statut:
ppublish
Résumé
Despite the growing emphasis on translational neuropharmacology and drug discovery research, the legality underlying these fields are seldom considered. The zebrafish (Danio rerio) is an increasingly utilized model organism in neuropharmacology and neurotoxicology. As the acceptance of zebrafish in biomedicine continues to grow, the legal aspects of their applications remain outpaced by this exponential growth. Therefore, there is a need to evaluate the legal aspects of zebrafish applications to CNS drug research. Here, we discuss a wide range of regulatory topics relevant to zebrafish research, such as the bioethics of experimentation (including studies of stress and pain), welfare protection laws, the recent advances in CNS drug discovery, and specific legal aspects of controlled substance research in this aquatic species. The conceptualization and understanding of the zebrafish welfare and its promise as a model in toxicology can also potentially shape environmental protection practices and inform policy making.
Identifiants
pubmed: 30453007
pii: S0273-2300(18)30299-X
doi: 10.1016/j.yrtph.2018.11.007
pii:
doi:
Substances chimiques
Central Nervous System Agents
0
Controlled Substances
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
65-70Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.